KHRN.VTSXVHealthcare · Drug Manufacturers - Specialty & Generic

Khiron Life Sciences Corp.

$0.04+0.00%(+$0.00)

TickerSpark Score

63/100

Mixed

100

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KHRN.V research report →

52-Week Range4% of range

Low $0.04

Current $0.04

High $0.17

Companykhiron.ca

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments.

CEO: Alvaro Francisco Torres
IPO: 2018
HQ: Vancouver, BC, CA

Price Chart

-75.76% · this period

Valuation

Market Cap: $9.30M
P/E: -0.20
P/S: 0.73
P/B: 0.20
EV/EBITDA: -0.12
Div Yield: 0.00%

Profitability

Gross Margin: 22.47%
Op Margin: -174.52%
Net Margin: -258.92%
ROE: -68.62%
ROIC: -61.04%

Growth & Income

Revenue: $12.79M · 59.60%
Net Income: $-33,129,000 · -37.81%
EPS: $-0.20 · 0.00%
Op Income: $-22,330,000
FCF YoY: 16.96%

Performance & Tape

52W High: $0.17
52W Low: $0.04
50D MA: $0.04
200D MA: $0.08
Beta: 2.64
Avg Volume: 208.82K

Get TickerSpark's AI analysis on KHRN.V

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime